2018 Speaking Faculty



Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Head, Market Access and Pricing
Merck KGaA


Jim Clement
Jim Clement
Executive Director, Cost of Care & Supply Chain Strategy
Aetna


John Garcia
John Garcia
Global Commercial Excellence Lead
Alnylam


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Brian Martinson
Brian Martinson
Specialty Pharmacy Leader
Lediant Biosciences, Inc.


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant


Stephanie Okey
Stephanie Okey, MS
Former Senior Vice President, Head of North America, Rare Diseases, US General Manager, Rare Diseases
Sanofi Genzyme


Jose Ricardo Perez
Jose Ricardo Perez, US CDMA
Executive Medical Director
Exelixis Inc


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Jenny Robertson
Jenny Robertson
Chief Counsel, Rare Disease Group, Pfizer Innovative Health
Pfizer


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Ravi Tayi
Ravi Tayi, MD, MPH
Vice President, Medical Affairs
Mallinckrodt Pharmaceuticals


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Amber Walker
Amber Walker
Director, Specialty Pharmacy Development-Rare and Orphan
Walgreens


Alex White
Alex White
Project Head, Agility & Rare Diseases, Global Product Strategy
Roche


Photo Not Available
Bryon Wornson
Vice President, Oncology Patient and Health Impact
IMPACT


Jim Wu
Jim Wu
Director, HTA CoE
Amgen


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy